Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Aug 8, 2024 · 10-Q · 39 days after period end · 0001437749-24-025611
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | $6.16M | -$26.38M | -$19.33M | -$5.13M |
| EPS Diluted | $0.13 | -$0.63 | -$0.48 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end
